Treatment for Primary CNS Lymphoma: The Next Step
Top Cited Papers
- 17 September 2000
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (17), 3144-3150
- https://doi.org/10.1200/jco.2000.18.17.3144
Abstract
PURPOSE: The use of preradiotherapy (RT) methotrexate (MTX) has improved disease control and survival in patients with primary CNS lymphoma (PCNSL). The reported protocol was designed to optimize a...Keywords
This publication has 15 references indexed in Scilit:
- Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma.Journal of Clinical Oncology, 1998
- Long-term survival in primary CNS lymphoma.Journal of Clinical Oncology, 1998
- Electrophysiologic testing of neuromuscular transmissionNeurology, 1997
- Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphomaNeurology, 1994
- Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcomeJournal of Neurosurgery, 1994
- The clinical spectrum of ocular lymphomaCancer, 1993
- Combined modality therapy for primary CNS lymphoma.Journal of Clinical Oncology, 1992
- Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315International Journal of Radiation Oncology*Biology*Physics, 1992
- Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function.Journal of Clinical Oncology, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958